… sample size of elderly patients or excluded elderly patients. Performing a prospective trial of
elderly patients is difficult because of comorbidities, the rarity of the patients, and decreasing …

… in clinical trials, it is uncertain if these recommendations are fitting for patients older than 70
… that elderly patients could benefit from double agents based concurrent chemoradiotherapy (…

… chemoradiotherapy is … elderly patients with LA-NSCLC has not been confirmed yet. We
evaluated the feasibility and efficacy of concurrent chemoradiotherapy (CCRT) for elderly patients …

… Modern CRT appears to confer a survival benefit compared to chemotherapy alone in a
recent retrospective analysis conducted on elderly patients with LD-SCLC. Age alone should not …

… These observations have not consistently been made in patients with other … elderly patients
treated with concurrent chemoradiotherapy have similar survival benefits as younger patients…

… of concurrent chemoradiotherapy (CRT) for head and neck squamous cell carcinoma patients
… This study examines the outcomes of elderly patients receiving CRT versus radiotherapy (…

… with MIBC most often are treated with radical cystectomy with or without neoadjuvant or
adjuvant chemotherapy, but bladder-preserving concurrent chemoradiotherapy (CCRT) after …

… study at a non-selected patient group. We hypothesize that in elderly patients, sequential
chemoradiotherapy may not be inferior to concurrent chemoradiotherapy in terms of survival. …

… actual clinical outcomes between concurrent chemoradiotherapy (CCRT) and … elderly
patients with stage III NSCLC may be inconsistent. Therefore, we should classify elderly patients …

… used for patients with locally advanced head and neck cancer, many elderly patients receive
… We evaluate acute and late toxicity among patients age ≥ 65 who received concurrent …